FORMULATION AND IN-VITRO EVALUATION OF THEOPHYLLINE HYDROCHLORIDE EFFERVESCENT FLOATING TABLETS: EFFECT OF POLYMER CONCENTRATION ON TABLET BUOYANCY

  • AKPABIO E. I. Pharmaceutics and Pharmaceutical Technology Department, Faculty of Pharmacy, University of Uyo, Nigeria
  • EFFIONG D. E. Pharmaceutics and Pharmaceutical Technology Department, Faculty of Pharmacy, University of Uyo, Nigeria https://orcid.org/0000-0002-9730-657X
  • UWAH T. O. Pharmaceutics and Pharmaceutical Technology Department, Faculty of Pharmacy, University of Uyo, Nigeria
  • SUNDAY N. I. National Institute for Pharmaceutical Research and Development (NIPRD) Garki, Abuja, Nigeria

Abstract

Objective: This study was undertaken to formulate a floating drug delivery system of theophylline hydrochloride using different concentrations of a chosen polymer and then investigate how polymer concentration affects buoyancy and drug release properties of the tablets.


Methods: Hydroxypropyl methylcellulose (HPMC) at different concentration levels of 15% (F1), 20% (F2) and 30% (F3) was used to form the three formulation batches of floating tablets. Wet granulation method was used for the granule preparation while Sodium bicarbonate and citric acid were used as the gas generating agent. The physical properties of the granules and the floating tablets were evaluated. Also determined were the physicomechanical properties, buoyancy and swelling characteristics of the tablets. The in vitro drug release study was carried out according to the USP I (basket method) for 8h in 900 ml 0.1N HCl at 50 rpm. Samples withdrawn at the regular predetermined time were analyzed spectrophotometrically at a wavelength of 271 nm and data obtained statistically analyzed by one-way analysis of variance (ANOVA). The differences between means were considered significant at P<0.05.


Results: The result showed that polymer (HPMC) concentration significantly (p>0.05) increased swelling index and improved floating lag time, it had no significant effect on the total floating time. Percentage drug release at the end of 8 h was 100%, 98.2% and 96.13% for formulation F1, F2 and F3, respectively. All three formulations followed the Higuchi drug release kinetics model and the mechanism of drug release was the non Fickian diffusion with exponents of 0.46, 0.51 and 0.56 for the respective batch.


Conclusion: Batch F3 gave a better-controlled drug release and floating properties in comparison to batch F1 and F2 thus Polymer concentration influenced the onset of floating and controlled the release of Theophylline.

Keywords: Theophylline, Buoyancy, Swelling index, Floating tablets, Gastric residence time

Downloads

Download data is not yet available.

References

1. Aulton ME, Kelvin TMG. Aulton’s pharmaceutics: the design and manufacture of medicines (4th ed.) Churchill Livingstone Elsevier; 2013. p. 30-61.
2. Bijumol C, Helen W, Jose K, Thomas K. Formulation and evaluation of floating tablets of theophylline. Hygeia J D Med 2013;5:23-31.
3. Nayak K, Ruma M, Biswarup D. Gastroretentive drug delivery systems: a review. Asian J Pharm Clin Res 2010;3:1-10.
4. Arora S, Javed A, Alka A, Roop K, Sanjula B. Floating drug delivery systems: a review. AAPS PharmSciTech 2005;6:372-90.
5. Nanda A, Chugh C. Gastroretentive drug delivery systems: a review. Int J Pharm Bio Sci 2017;8:62-8.
6. Aitipamula S, Wong BH, Kanaujia P. Evaluating suspension formulations of theophylline cocrystals with artificial sweeteners. J Pharm Sci 2018;107:604-11.
7. Riahi S, Mousavi MF. A novel potentiometric sensor for selective determination of theophylline: theoretical and practical investigations. Anal Chem Acta 2005;548:192-8.
8. Kendre PN, Lateef SN, Godge RK, Chaudhari PD, Fernandes SL, Vibhute SK. Oral sustained delivery of theophylline floating matrix tablets-formulation and in vitro evaluation. Int J PharmTech Res 2010;2:130-9.
9. Srikanth Meka V, Ee Li C, Sheshala R. Design and statistical optimization of an e?ervescent ?oating drug delivery system of theophylline using response surface methodology. Acta Pharm 2016;66:35–51.
10. Ofoefule SI, Chukwu A. Binding property of Treculia africana gum in sodium salicylate tablets. STP Pharma Sci 1994;4:394–8.
11. Rakhi B, Shah, Tawakul MA, Khan MA. Comparative evaluation of flow for pharmaceutical powders and granules. AAPS PharmSciTech 2008;9:250-8.
12. British Pharmacopoeia. Pharmaceutical Press, Cambridge, London; 2008.
13. Quereshi J, Ijaz H, Sethi A, Zaman M, Bashir I, Hanif M, et al. Formulation and in vitro evaluation of sustained release matrix tablets of metoprolol tartrate using synthetic and natural polymers. Lat Am J Pharm 2014;33:1533-9.
14. Kiattisak S, Yanee P, Helmet V, Siripon O. Factors influencing drug dissolution characteristics from hydrophilic polymer matrix tablet. Sci Pharm 2007;75:147-64.
15. Nur AO, Zhang JS. Captopril floating and/or bioadhesive tablets: design and release kinetics. Drug Dev Ind Pharm 2000;26:965-9.
16. Alderborn G, Nystrom C. Studies on direct compression of tablets XIV: the effect of powder fineness on the relation between tablets permeametry surface and compaction pressure. Powder Technol 1985;44:37–42.
17. USP28. The United States Pharmacopeia 28: The National Formulary 23. United States Pharmacopeial Convention; 2004.
18. Juppo AM, Yliruusi J. Effect of amount of granulation liquid on total pore volume and pore size distribution of Lactose, glucose and mannitol granule. Eur J Pharm Bio Pharm 1994;40:299-309.
19. Yassin S, Goodwin DJ, Zeitler AJ. The disintegration process in microcrystalline S cellulose-based tablet; the influence of temperature, porosity and superdisintegrants. J Pharm Sci 2015;104:76-93.
20. Spath S, Drescher P, Herman H. Impact of particle size of ceramic blends on mechanical strength and porosity of 3D printed scaffolds. Material 2015;8:4720–32.
21. Jeong SH, Thapa P. Effects of formulation and process variables on gastroretentive floating tablets with a high dose soluble drug and experimental design approach. Pharmaceutics 2018;10:1-25.
22. Reza MS, Quadir MA, Haider SS. Comparative evaluation of rate of hydration and matrix erosion of HEC and HPC and study of drug release from their matrices. Eur J Pharm Sci 2003;16:193-9.
23. Wan SC, Heng WS, Wong LP. Relationship between swelling and drug release in the hydrophilic matrix. Drug Dev Ind Pharm 1993;19:1201-10.
24. Venkateswarlu K, Preethi KJ, Kiran BS. Formulation development and in vitro evaluation of floating tablets of ciprofloxacin HCL. Asian J Pharm 2016;10:271-8.
25. Gunjal PT, Gharge VS, Pimple SV, Gurjar MK, Shah MN. Design, development and optimization of S (-) atenolol floating sustained release matrix tablets using surface response method. Ind J Pharm Sci 2015;77:565-72.
26. Conti S, Maggi L, Segale L, Machiste EO, Conte U, Grenier P, Vergnault G. Matrices containing NaCMC and HPMC: I. Dissolution performance characterization. Int J Pharm 2007;333:136–42.
Statistics
124 Views | 111 Downloads
Citatons
How to Cite
E. I., A., E. D. E., U. T. O., and S. N. I. “FORMULATION AND IN-VITRO EVALUATION OF THEOPHYLLINE HYDROCHLORIDE EFFERVESCENT FLOATING TABLETS: EFFECT OF POLYMER CONCENTRATION ON TABLET BUOYANCY”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 12, no. 1, Dec. 2019, pp. 59-65, doi:10.22159/ijpps.2020v12i1.35055.
Section
Original Article(s)